Determinants of prognosis of acute transverse myelitis in children

Reiko Miyazawa1, Yuka Ikeuchi, Takeshi Tomomasa

  • 1Department of Pediatrics, Tone Central Hospital, Numata, Gunma University School of Medicine, Maebashi and Saku Central Hospital, Minamisaku, Nagano, Japan.

Insights

Younger children and those with specific neurological signs like increased reflexes or Babinski reflex had poorer outcomes for acute transverse myelitis (ATM). Steroid treatment did not improve prognosis in this study.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Acute transverse myelitis (ATM) is a severe neurological disorder with prolonged recovery and potential for lasting deficits.
  • Predicting prognosis in pediatric ATM is crucial for patient management and understanding disease course.

Purpose of the Study:

  • To identify key features influencing long-term neurologic outcomes in Japanese children diagnosed with acute transverse myelitis.
  • To analyze the impact of demographic and acute-phase clinical characteristics on ATM prognosis.

Main Methods:

  • Retrospective analysis of 50 Japanese pediatric ATM cases (1987-2001).
  • Regression analysis correlating demographic and acute-phase features (age, reflexes, sex, infection, treatment) with long-term neurologic deficits.
  • Dependent variable: persistence of neurologic deficits; Independent variables: various clinical and treatment factors.

Main Results:

  • Younger age, absence of increased deep tendon reflexes, and absence of Babinski reflex were associated with higher likelihood of residual neurologic deficits (paraplegia, tetraplegia, sensory loss, sphincter disturbance).
  • No significant correlation found between prognosis and sex, preceding infections, decreased deep tendon reflexes, time course of impairment, or timing/use of steroid therapy (prednisolone/methylprednisolone).

Conclusions:

  • Age at onset and specific neurologic findings are significant predictors of outcome in pediatric acute transverse myelitis.
  • Current evidence suggests steroid therapy does not improve long-term prognosis for ATM in this population.
Abstract

Related Concept Videos